^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    GENE:

    ATP2B1-AS1 (ATP2B1 Antisense RNA 1)

    i
    Other names: ATP2B1-AS1, ATP2B1 Antisense RNA 1, Long Intergenic Non-Protein Coding RNA 936, LINC00936, NONHSAG011873.2, HSALNG0092957, ATP2B1-AS1
    Associations

    News

    Trials
    9ms
    A Prognostic Model for Senescence-Related LncRNA in a Novel Colon Adenocarcinoma Based on WGCNA and LASSO Regression. (PubMed, Biomedicines)
    A significant correlation was observed between the senescence-related lncRNA prognostic model and the tumor microenvironment, immune cell infiltration, and drug sensitivity (p < 0.05). The senescence-related lncRNA prognostic model developed in this work can accurately forecast the prognosis of colon cancer patients, offering new insights for personalized treatment approaches in colon cancer.
    Journal
    |
    ATP2B1-AS1 (ATP2B1 Antisense RNA 1)
    2years
    Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression. (PubMed, J Cardiothorac Surg)
    ATP2B1-AS1 sponge miR-141-3p alleviated the progression of LUAD, and ATP2B1-AS1 may be deemed as a prognostic marker for LUAD.
    Journal
    |
    MIR141 (MicroRNA 141) • ATP2B1-AS1 (ATP2B1 Antisense RNA 1)
    |
    miR-141 expression
    over2years
    Identification of mC-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients. (PubMed, Sci Rep)
    At the same time, we found significant differences in the responses to chemoradiotherapy between the two groups, proving the value of mC-LPS in treatment decision-making in ESCC. This study established a novel prognostic signature based on 9 mC-related lncRNAs, which is a promising biomarker for predicting clinical outcomes and therapeutic response in ESCC.
    Journal
    |
    ATP2B1-AS1 (ATP2B1 Antisense RNA 1)